SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Legend Biotech appoints Novartis veteran Ingrid Zhang as CEO

Legend Biotech (NASDAQ:LEGN) appointed longtime Novartis executive Ingrid Zhang as CEO, effective immediately.

AZNLEGN

Legend Biotech NASDAQ:LEGN on Tuesday appointed longtime Novartis BX:NOT executive Ingrid Zhang as its CEO, effective immediately, as the company looks to an industry veteran to guide its expansion beyond blockbuster cancer therapy Carvykti. Zhang most recently served as Novartis' international…